Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II single-arm study of goserelin + exemestane in premenopausal metastatic breast cancer
ChiCTR-ONC-13003946Phase 2Completed
- Sponsor
- Cancer Institute (WIA)
- Start
- Oct 2010
- Modality
- Small Molecules, Peptides
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of goserelin and exemestane in breast cancer, sponsored by Cancer Institute (WIA). Primary endpoint: objective response rate. Started Oct 2010; status: completed.
02
Drugs
goserelinexemestane
03
Conditions
breast cancer
Beyond the preview
Go deeper on ChiCTR-ONC-13003946.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-ONC-13003946.